Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Accumulated Depreciation (2021 - 2026)

Cingulate's (CINGW) quarterly Accumulated Depreciation came in at $4.1 million in Q2 2026, up 12.42% on a YoY basis from $3.6 million in Q2 2025, and up 5.72% quarter-over-quarter from $3.8 million in Q4 2025.

Analysis

Cingulate (CINGW) Accumulated Depreciation (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Accumulated Depreciation for 6 consecutive years, with $4.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accumulated Depreciation rose 12.42% year-over-year to $4.1 million; the trailing twelve-month figure through Jun 2026 stood at $4.1 million (up 12.42% YoY), and the FY2025 full-year result was $3.8 million, up 16.41% from the prior year.
  • Accumulated Depreciation improved to $4.1 million in Q2 2026 per CINGW's latest filing, from $3.8 million in the prior quarter.
  • Across five years, Accumulated Depreciation topped out at $4.1 million in Q2 2026 and bottomed at $1.8 million in Q1 2022.
  • Historically, Accumulated Depreciation has averaged $2.8 million across 5 years, with a median of $2.8 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Accumulated Depreciation gained 29.89% in 2024, then gained 12.42% in 2026.
  • Over 5 years, Accumulated Depreciation stood at $2.1 million in 2022, then increased by 28.3% to $2.6 million in 2023, then gained by 24.71% to $3.3 million in 2024, then gained by 16.41% to $3.8 million in 2025, then climbed by 5.72% to $4.1 million in 2026.
  • According to Business Quant data, Accumulated Depreciation over the past three periods registered $4.1 million, $3.8 million, and $3.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.24 Bn 625.48 Bn 17.26 Bn
2 AbbVie 441.52 Bn 434.96 Bn 12.70 Bn
3 Merck 365.75 Bn 358.60 Bn 12.21 Bn
4 Novartis Ag 266.61 Bn 258.92 Bn 11.24 Bn
5 Pfizer 159.09 Bn 147.39 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.04 Bn 44.04 Bn -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn
9 United Therapeutics 21.43 Bn 18.77 Bn 683.80 Mn
10 Cingulate 100,214.03 100,214.03 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.06 Mn
Dec 31, 2025 3.84 Mn
Sep 30, 2025 3.72 Mn
Jun 30, 2025 3.61 Mn
Mar 31, 2025 3.46 Mn
Dec 31, 2024 3.30 Mn
Sep 30, 2024 3.14 Mn
Jun 30, 2024 2.97 Mn
Mar 31, 2024 2.81 Mn
Dec 31, 2023 2.64 Mn
Sep 30, 2023 2.47 Mn
Jun 30, 2023 2.32 Mn
Mar 31, 2023 2.16 Mn
Dec 31, 2022 2.06 Mn
Sep 30, 2022 1.97 Mn
Jun 30, 2022 1.87 Mn
Mar 31, 2022 1.77 Mn
Dec 31, 2021 1.67 Mn